Skye Bioscience, Inc.

SKYE ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet › Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2022

Total Assets: $9.1M

Liabilities Breakdown FY2022

Total Liabilities: $12.1M